Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
George Kiloh
Observed name:
G. Kiloh
OpenAlex ID:
A5099059404
Development of optimised human iPSC-derived hepatocytes with improved liver function for in vitro metabolic disease modelling and toxicity studies
2024
·
Magdalena Łukasiak
, Gemma Gatti
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
4
iPSC-derived hepatocytes accurately recapitulate population diversity in alpha-1-antitrypsin deficiency and offer a novel in vitro model for large-scale drug efficacy screening studies
2025
·
Carlos Gil
, Vanesa Papastavrou
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
iPSC-derived hepatocytes offer a novel platform for modelling metabolic dysfunction-associated steatotic liver disease (MASLD) in vitro
2025
·
Magdalena Lukasiak
, Samuel Chung
, et al.
·
Endocrine Abstracts
P02-26 Optimized iPSC-derived hepatocytes offer a novel liver cell model for in vitro predictive toxicity and drug efficacy studies
2024
·
M. Lukasiak
, G. Gatti
, et al.
·
Toxicology Letters
P02-36 In vitro monogenic liver disease models using iPSC-derived hepatocytes demonstrate an altered CYP450 gene expression profile compared to wild-type cells
2024
·
M. Haddad
, G. Gatti
, et al.
·
Toxicology Letters
FRI-542 Induced pluripotent stem cell-derived hepatocytes revisited: improved liver functionality compared to liver cancer cell lines and a better model for pre-clinical large-scale therapeutic screening and drug safety
2024
·
Magdalena Lukasiak
, Gemma Gatti
, et al.
·
Journal of Hepatology
Show more works
View as search
Works count:
6
Citation count:
6
H-index:
2
I10-index:
Year
Topic
Type
